Can the FDA Prevent the "Uberification" of the Healthcare Industry? | Pharmaguy's Insights Into Drug Industry News |

Bertalan Mesko, MD, PhD, a European "medical futurist," says "The system of drug regulation is obsolete. To keep patients around the world safe, authorities like the US FDA must step up and deal with disruptive trends – without suffocating innovation."

Innovation in medicine is getting faster while the processes the US Food and Drug Administration (FDA) uses are sometimes decades old. The Patient Engagement Advisory Committee, launched in September 2015, was a great step forward. But regulators are unprepared for some big changes on the horizon.

Here's one of the top five issues that Mesko believe will shape the future of the regulatory environment.

The 'Uberification' of healthcare

Uber has caused protests around the world by disrupting the taxi industry through making transportation available at lower prices. The company's success and price advantage was made possible in no small part through avoiding regulations. If on-demand care delivery services gain popularity in the same way, before proper regulations are put in place, the resulting chaos will threaten patients' health and caregivers' livelihoods.

The FDA will have to be at its best to prevent this. And it must hurry up - The Heal app ( and Go2Nurse in Chicago ( have already started this disruption around how healthcare is delivered.